AB Disruptors ETF
NYSEARCA:FWDThe AB Disruptors ETF (FWD) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of high growth stocks of companies considered to lead or benefit from societal innovations. Holdings may be of any capitalization, sector, industry, and geography. FWD was launched on Mar 22, 2023 and is managed by AllianceBernstein.
Revelation Biosciences
NASDAQ:REVBRevelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-100, a potential therapy for the prevention and treatment of healthcare-associated bacterial infection resulting from surgery, severe burns, urinary tract infection, sepsis, and antibiotic resistance; REVTx-200, a potential intranasal therapy; and REVTx-300, a potential therapy for the treatment of chronic organ disease, including chronic kidney disease. It is also developing REVTx-99b, a treatment for food allergies; REVTx-99a, an anti-viral nasal drop solution for the potential prevention or treatment of respiratory viral infection; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, influenza A, influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.
